Trump Targets Global Drug Pricing Policies

President Donald Trump is set to sign an executive order on Monday that targets what the U.S. administration sees as discriminatory drug pricing policies abroad. A White House official revealed the order aims to curb practices that suppress drug prices in foreign countries.

During a briefing with reporters, the official stated that if expected progress with the drug industry does not materialize, the Department of Health and Human Services will impose 'most favored nation' pricing via new rules.

The move signifies a more aggressive stance in addressing international drug pricing, which the administration argues unfairly disadvantages American consumers and pharmaceutical companies.

(With inputs from agencies.)